Q3 2015 Holdings
Filed 2015-11-16 | 74 holdings | $7.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $2.6M | 225,000 | 34.1% |
| Cellectis(CLLS) | SPONSORED ADS | 15117K103 | $2.0M | 75,000 | 26.3% |
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $1.7M | 97,135 | 22.8% |
| Catalyst Pharm Partners Inc(CPRX) | COM | 14888U101 | $1.1M | 350,000 | 14.0% |
| Allergan PLC | SHS | G0177J108 | $10.2K | 37,500 | 0.1% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $8.4K | 175,000 | 0.1% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $7.7K | 500,000 | 0.1% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $7.7K | 120,000 | 0.1% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $7.5K | 235,000 | 0.1% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $7.2K | 450,000 | 0.1% |
| Amgen Inc(AMGN) | COM | 031162100 | $6.9K | 50,000 | 0.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $6.9K | 70,000 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $6.5K | 60,000 | 0.1% |
| Alnylam Pharmaceuticals IncCall | COM | 02043Q907 | $6.0K | 75,000 | 0.1% |
| Bristol Myers Squibb CoCall | COM | 110122908 | $5.9K | 100,000 | 0.1% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $5.7K | 350,000 | 0.1% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $5.7K | 40,000 | 0.1% |
| Horizon Pharma PLC | SHS | G4617B105 | $5.5K | 275,000 | 0.1% |
| Community Health SYS Inc New(CYH) | COM | 203668108 | $5.1K | 120,000 | 0.1% |
| Zogenix Inc | COM | 98978L204 | $5.0K | 370,000 | 0.1% |
| Heartware Intl Inc | COM | 422368100 | $4.7K | 90,000 | 0.1% |
| Integra Lifesciences Holdings Corp(IART) | COM | 457985208 | $4.5K | 75,000 | 0.1% |
| Alcobra LTD | SHS | M2239P109 | $4.2K | 688,961 | 0.1% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $4.1K | 525,000 | 0.1% |
| Dynavax Technologies Corp | COM | 268158102 | $4.0K | 165,000 | 0.1% |
| HCA Holdings Inc(HCA) | COM | 40412C101 | $3.9K | 50,000 | 0.1% |
| Aegerion Pharmaceuticals Inc | COM | 00767E102 | $3.4K | 250,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $3.3K | 80,000 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $3.2K | 7,000 | 0.0% |
| Synergy Pharmaceuticals Inc | COM | 871639308 | $3.2K | 600,000 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $3.1K | 100,000 | 0.0% |
| Uniqure B.V.(QURE) | SHS | N90064101 | $3.1K | 150,000 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $2.9K | 250,000 | 0.0% |
| Therapeuticsmd IncCall | COM | 88338N907 | $2.9K | 500,000 | 0.0% |
| Bellicum Pharmaceuticals Inc | COM | 079481107 | $2.9K | 200,000 | 0.0% |
| Cynapsus Therapeutics Inc | COM | 23257Y859 | $2.8K | 175,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $2.8K | 25,000 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $2.8K | 250,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $2.7K | 30,000 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $2.7K | 100,000 | 0.0% |
| Heron Therapeutics IncCall | COM | 427746902 | $2.4K | 100,000 | 0.0% |
| Relypsa Inc | COM | 759531106 | $2.2K | 120,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.2K | 55,000 | 0.0% |
| Tonix Pharmaceuticals Holdin | COM | 890260201 | $2.1K | 398,300 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $2.1K | 65,000 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $2.1K | 300,000 | 0.0% |
| Neuroderm LTD | COM | M74231107 | $2.1K | 100,000 | 0.0% |
| PTC Therapeutics IncCall | COM | 69366J900 | $2.0K | 75,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $1.9K | 150,000 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $1.7K | 300,000 | 0.0% |